Navigation Links
CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
Date:5/1/2008

http://www.cryocath.com Toronto Stock Exchange Symbol: CYT

MONTREAL, May 1 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its second quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Monday, May 12, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Monday, May 12.

DATE: Monday, May 12, 2008

TIME: 4:30 p.m., Eastern Standard Time

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

(Available until May 19, 2008)

REFERENCE NUMBER: 21270226

WEBCAST: A live audio webcast of the call will be available at

http://www.cryocath.com. Webcast attendees are welcome to listen to

the conference in real-time or on-demand at their convenience.

The webcast will be archived for 365 days. Please connect to

this website at least 15 minutes prior to the conference call

to ensure adequate time for any software download that may be

needed to hear the webcast.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legi
'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
2. CryoCath Introduces Arctic Front in Australia
3. CryoCath Appoints New Chief Financial Officer
4. CryoCath Technologies notice of annual meeting
5. CryoCath Announces Fiscal 2008 First Quarter Results
6. CryoCath Provides Update on Patent Infringement Lawsuit
7. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
8. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
9. CryoCath announces 2007 fourth quarter and fiscal year end financial results
10. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
11. CryoCath to present at CIBC Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...rm would control health care costs, Leapfrog,s pur...ough example -- delivering the best quality care i... efficiency. Thirty-four urban, eight children,s a...frog Top Hospitals, based on results from The Leap...
(Date:12/4/2009)...Western Reserve University researchers, from the S...vered two new metabolic pathways by which products...own as 4-hydroxyacids, are metabolized. The pathwa...s and mass isotopomer analysis. The findings shed ...f abuse gamma-hydroxybutyrate, also known as "the ...
(Date:12/4/2009)...ing exercise, water and fruit consumption leads t.... 4 (HealthDay News) -- Increased exercise, reduce... most effective weight control strategies for adol...yed 130 adolescents about their weight-control str...ded in losing weight and 68 had not. The responses...
(Date:12/4/2009)... the H1N1 virus will come back during winter isn,t...ealthDay News) -- The number of states reporting w...this week -- to 25 from a high of 48 just two week...anwhile, the supply of H1N1 swine flu vaccine cont... of the U.S. Centers for Disease Control and Preve...
(Date:12/4/2009)... TrekDesk Inventor Showcasing In... (Vocus) December 4, 2009 -- A valle...vention proven to help individuals lose weight, pr...ost productivity will be showcasing the product at...ivic Center Gallery., , , , , TrekDesk has been ...
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Swine Flu Continues to Wane 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2
...nhanced Benefits Program Linking Oral Health and O... of Illinois is,offering a new benefits program to... "Smile Smart for Your Health," integrates oral he...riodontal,disease or surgery. (Logo: http://www....
... A father-son research team working from separate...red a new use for lasers - zapping viruses out of ...infecting blood for transfusions, uses a low-power...e park with his father that the idea was born. Ts...
...DISON, N.J., Sept. 4 Marlabs, Inc. has been named...tsourcing list of Top 10 BPO,healthcare revenue cy...nvitations were issued to outsourcing users and,de...tes the recognition to their,commitment to custome...
...uction Proceeds to Benefit St. Jude Children,s Res...iture, a leading specialty,retailer of furniture, ...,after a live online auction, its celebrity signed...ties including,Elisabeth Hasselbeck, Barbara Walte...
...tudy found twice the success rate when parents too...althDay News) -- Parents can play a significant ro...tudy has found. , When parents were involved in a ...ften been seen as part of the problem, rather than...
...BBOTT PARK, Ill., Sept. 4 Abbott (NYSE: ABT ),wi...are Conference on,Tuesday, Sept. 11, 2007. Thomas ...hief financial officer, will make a formal present...ite at http://www.abbottinvestor.com . An,archive...
Other Medicine News:Health News:Delta Dental of Illinois Introduces 'Smile Smart For Your Health' 2Health News:Delta Dental of Illinois Introduces 'Smile Smart For Your Health' 3Health News:Laser blasts viruses in blood 2Health News:Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 2Health News:Celebrity Seating Only! Levitz Chair Signed by 39 Daytime Stars Sells for $1200 on Charitybuzz.com 2Health News:Parental Involvement Key to Battling Bulimia 2Health News:Parental Involvement Key to Battling Bulimia 3
(Date:12/3/2009)...enmark and SAN DIEGO, California, December 3 /PRNe...its miR-122, a microRNA Important for,Hepatitis C ...Hepatitis C,Virus in the Bloodstream in Chimpanzee..., - SPC3649 Demonstrates Efficacy With No...se Events in the Treated Animals - Signaling a Pot...
(Date:12/3/2009)...Newswire-USNewswire/ -- In response to the increas...nologies in the evolving healthcare delivery syste...ealth Informatics (DCHI) to provide a campus focus...vative interdisciplinary approach to education tha...ses and healthcare administrators with an expertis...
(Date:12/3/2009)...wswire-FirstCall/ -- Cardium Therapeutics (NYSE Am...ubsidiary, Tissue Repair Company, submitted a 510(...d and Drug Administration (FDA) seeking marketing ...e based on positive data from the Company,s recent...y,s submission with the FDA covers Excellagen XL(T...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 1InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 3Max Neeman International to Open Phase I IIa Unit 14233 1Max Neeman International to Open Phase I IIa Unit 14233 2Is inhaled insulin delivery still a possibility 3F Why has it been a commercial failure 3F 58149 1Is inhaled insulin delivery still a possibility 3F Why has it been a commercial failure 3F 58149 2
...) HBSAG Test Found to Have Higher Sensitivity and ...stVue(TM) ,...and was the preferred ...RINGS, Fla., Oct. 13 AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
...y stent features thin struts designed for more uni... NATICK, Mass., and WASHINGTON, Oct. 12 Boston,S...d comprehensive data from,the TAXUS ATLAS clinical...nter, single-arm, historically controlled trials, ...Eluting Stent System in a variety of,lesions and p...
Other Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6
High-sensitive CRP Control
MONO Mononucleosis Rapid Test Device
... management software enables you to automate your ... Use Pipette Tracker to create a schedule for pipe...set tolerances and immediately see Pass/Fail statu...rts. Pipette Tracker enables increased efficiency ...
... is an innovative, safe and effective surgical app...ence in men following prostatectomy. It also is a ...ificial urinary sphincter due to limited manual de...ence., ,InVance uses a mesh sling, anchored wi...
Medicine Products: